mirage

Stress and the brain : new challenge for psychopharmacology / Brian H. Harvey

Boloka/Manakin Repository

Show simple item record

dc.contributor.author Harvey, Brian H
dc.date.accessioned 2012-03-22T07:27:13Z
dc.date.available 2012-03-22T07:27:13Z
dc.date.issued 2005
dc.identifier.isbn 1868224724
dc.identifier.uri http://hdl.handle.net/10394/6361
dc.description.abstract Anxiety and mood disorders such as panic, obsessive compulsive disorder (OCD), posttraumatic stress disorder (PTSD) and depression are amongst the most prevalent, disabling, and chronic of all the psychiatric disorders. Neuropsychiatric disorders comprise the second largest component of the burden of disease in South Africa. To compound the problem, under-diagnosis and current treatments that are in most cases less than adequately effective, contributes to an enormous personal and economic cost to the patient and his/her family. Recent brain imaging studies in PTSD and depression have emphasized that these illnesses may induce damaging effects on regions of the brain involved in regulating the response to stress. While controversy prevails as to whether these changes represent an adaptive process or are indeed pathological they are associated with marked changes in memory and other cognitive functions. In depression, a history of prior episodes are correlated with a higher risk of relapse, while poor compliance with antidepressants not only predicts later relapse, it may result in a more shrinkage of the above-mentioned brain regions. Perhaps the structural change caused by prolonged depressive illness explains why recurrent episodes are less responsive to treatment. Similarly, even with the introduction of effective medications for PTSD, many patients remain treatment-resistant. However, does stress damage the brain and if so, are the mechanisms and prompts for its induction different for these disorders? Clearly, understanding their pathological basis will assist in developing more effective treatment strategies. This paper will highlight at least one potential new avenue for future psychotropic drug research in depression and anxiety disorders, viz. the glutamate-nitric oxide-cGMP pathway. en_US
dc.publisher Potchefstroom : Noordwes-Universiteit, Potchefstroomkampus (Suid-Afrika) en_US
dc.relation.ispartofseries Wetenskaplike bydraes van die PU vir CHO. Reeks H, Inougurele redes ; nr. 164
dc.subject Psychotropic drugs - Physiological effect. en_US
dc.subject Psigotropiese middels - Fisiologiese effek en_US
dc.title Stress and the brain : new challenge for psychopharmacology / Brian H. Harvey en_US
dc.type Other en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search the NWU Repository


Advanced Search

Browse

My Account

Statistics